FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2558903543> ?p ?o ?g. }

• W2558903543 endingPage "357" @default.
• W2558903543 startingPage "340" @default.
• W2558903543 abstract "Long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) combinations are a treatment option for patients with COPD who continue to have symptoms despite treatment with a LAMA or a LABA alone. The Efficacy and Safety of PT003, PT005, and PT001 in Subjects with Moderate-to-Very Severe COPD (PINNACLE-1) (NCT01854645) and the Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects with Moderate-to-Very Severe COPD (PINNACLE-2) (NCT01854658) trials investigated the efficacy and safety of a novel glycopyrrolate [GP]/formoterol [FF] 18/9.6-μg (GFF) metered dose inhaler (MDI) formulated using the Co-Suspension Delivery Technology in patients with moderate-to-very severe COPD.These two phase III trials took place over 24 weeks and were randomized, double blind, and placebo controlled; 2,103 and 1,615 patients (40-80 years of age), respectively, were randomized. Patients received GFF MDI, GP MDI 18 μg, FF MDI 9.6 μg, or placebo MDI (all twice daily), or tiotropium 18 μg dry powder inhaler (once daily in PINNACLE-1 only [open-label active comparator]). Efficacy and safety were assessed.At week 24, differences in change from baseline in the morning predose trough FEV1 for GFF MDI vs placebo MDI, GP MDI, and FF MDI were 150 mL, 59 mL, and 64 mL in PINNACLE-1 (all P < .0001) and 103 mL, 54 mL, and 56 mL in PINNACLE-2 (all P < .001), respectively. There were no significant safety findings (incidence of adverse events was similar between treatment arms).We conclude that GFF MDI 18/9.6 μg demonstrated superiority over placebo and monocomponent MDIs and was well tolerated, thus providing an additional treatment option for patients with moderate-to-very severe COPD.ClinicalTrials.gov; No.: NCT01854645 and No. NCT01854658; URL: www.clinicaltrials.gov." @default.
• W2558903543 created "2016-12-08" @default.
• W2558903543 creator A5002603430 @default.
• W2558903543 creator A5004283619 @default.
• W2558903543 creator A5010278392 @default.
• W2558903543 creator A5011502862 @default.
• W2558903543 creator A5011605095 @default.
• W2558903543 creator A5015887122 @default.
• W2558903543 creator A5027975503 @default.
• W2558903543 creator A5028265360 @default.
• W2558903543 creator A5039590450 @default.
• W2558903543 creator A5052421515 @default.
• W2558903543 creator A5059374169 @default.
• W2558903543 creator A5068530585 @default.
• W2558903543 creator A5070315113 @default.
• W2558903543 creator A5075950948 @default.
• W2558903543 creator A5077419098 @default.
• W2558903543 creator A5082568705 @default.
• W2558903543 creator A5083270547 @default.
• W2558903543 creator A5088367060 @default.
• W2558903543 creator A5090165536 @default.
• W2558903543 date "2017-02-01" @default.
• W2558903543 modified "2023-10-11" @default.
• W2558903543 title "Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD" @default.
• W2558903543 cites W1667532038 @default.
• W2558903543 cites W1950043623 @default.
• W2558903543 cites W2017287154 @default.
• W2558903543 cites W2024631328 @default.
• W2558903543 cites W2026585673 @default.
• W2558903543 cites W2030987445 @default.
• W2558903543 cites W2039237831 @default.
• W2558903543 cites W2056040906 @default.
• W2558903543 cites W2086199047 @default.
• W2558903543 cites W2105402505 @default.
• W2558903543 cites W2122286642 @default.
• W2558903543 cites W2125078269 @default.
• W2558903543 cites W2128643475 @default.
• W2558903543 cites W2133160180 @default.
• W2558903543 cites W2134820467 @default.
• W2558903543 cites W2142449488 @default.
• W2558903543 cites W2155854731 @default.
• W2558903543 cites W2165446260 @default.
• W2558903543 cites W2166432084 @default.
• W2558903543 cites W2171974515 @default.
• W2558903543 cites W2317895461 @default.
• W2558903543 cites W2365138737 @default.
• W2558903543 cites W243325842 @default.
• W2558903543 cites W2508659471 @default.
• W2558903543 cites W2518607452 @default.
• W2558903543 cites W2520775112 @default.
• W2558903543 doi "https://doi.org/10.1016/j.chest.2016.11.028" @default.
• W2558903543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27916620" @default.
• W2558903543 hasPublicationYear "2017" @default.
• W2558903543 type Work @default.
• W2558903543 sameAs 2558903543 @default.
• W2558903543 citedByCount "89" @default.
• W2558903543 countsByYear W25589035432017 @default.
• W2558903543 countsByYear W25589035432018 @default.
• W2558903543 countsByYear W25589035432019 @default.
• W2558903543 countsByYear W25589035432020 @default.
• W2558903543 countsByYear W25589035432021 @default.
• W2558903543 countsByYear W25589035432022 @default.
• W2558903543 countsByYear W25589035432023 @default.
• W2558903543 crossrefType "journal-article" @default.
• W2558903543 hasAuthorship W2558903543A5002603430 @default.
• W2558903543 hasAuthorship W2558903543A5004283619 @default.
• W2558903543 hasAuthorship W2558903543A5010278392 @default.
• W2558903543 hasAuthorship W2558903543A5011502862 @default.
• W2558903543 hasAuthorship W2558903543A5011605095 @default.
• W2558903543 hasAuthorship W2558903543A5015887122 @default.
• W2558903543 hasAuthorship W2558903543A5027975503 @default.
• W2558903543 hasAuthorship W2558903543A5028265360 @default.
• W2558903543 hasAuthorship W2558903543A5039590450 @default.
• W2558903543 hasAuthorship W2558903543A5052421515 @default.
• W2558903543 hasAuthorship W2558903543A5059374169 @default.
• W2558903543 hasAuthorship W2558903543A5068530585 @default.
• W2558903543 hasAuthorship W2558903543A5070315113 @default.
• W2558903543 hasAuthorship W2558903543A5075950948 @default.
• W2558903543 hasAuthorship W2558903543A5077419098 @default.
• W2558903543 hasAuthorship W2558903543A5082568705 @default.
• W2558903543 hasAuthorship W2558903543A5083270547 @default.
• W2558903543 hasAuthorship W2558903543A5088367060 @default.
• W2558903543 hasAuthorship W2558903543A5090165536 @default.
• W2558903543 hasBestOaLocation W25589035431 @default.
• W2558903543 hasConcept C126322002 @default.
• W2558903543 hasConcept C142724271 @default.
• W2558903543 hasConcept C201645570 @default.
• W2558903543 hasConcept C204787440 @default.
• W2558903543 hasConcept C27081682 @default.
• W2558903543 hasConcept C2775859210 @default.
• W2558903543 hasConcept C2776017024 @default.
• W2558903543 hasConcept C2776042228 @default.
• W2558903543 hasConcept C2776136866 @default.
• W2558903543 hasConcept C2776780178 @default.
• W2558903543 hasConcept C2776954882 @default.
• W2558903543 hasConcept C2777419714 @default.
• W2558903543 hasConcept C2779871671 @default.
• W2558903543 hasConcept C2780261241 @default.

• next